IGC
IGC
AMEX · Pharmaceuticals

Igc Pharma Inc

$0.27
0.00 (-0.60%)
As of Jun 23, 10:10 PM ET ·
Financial Highlights (FY 2026)
Revenue
980.9K
Net Income
-4,674,264
Gross Margin
34.2%
Profit Margin
-477.1%
Rev Growth
-1.5%
D/E Ratio
0.02
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 34.2% 34.2% 57.7% 57.7%
Operating Margin -891.2% -802.1% 15.4% 17.4%
Profit Margin -477.1% -453.3% 15.5% 13.2%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 980.9K 996.0K 13.95M 13.36M
Gross Profit 335.3K 340.4K 8.05M 7.71M
Operating Income -8,742,217 -7,989,434 2.14M 2.33M
Net Income -4,674,264 -4,271,768 2.16M 1.76M
Gross Margin 34.2% 34.2% 57.7% 57.7%
Operating Margin -891.2% -802.1% 15.4% 17.4%
Profit Margin -477.1% -453.3% 15.5% 13.2%
Rev Growth -1.5% -1.5% +17.1% -6.7%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 244.6K 244.6K 9.96M 10.38M
Total Equity 13.51M 13.51M 19.20M 17.06M
D/E Ratio 0.02 0.02 0.52 0.61
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -8,357,625 -8,062,290 3.52M 3.64M
Free Cash Flow 2.06M 1.63M